menu close

Optimising pharmacovigilance for lifescience companies

We provide innovative software and specialist services that optimise business-critical pharmacovigilance processes for global pharmaceutical and life sciences companies – streamlining your regulatory and operational responsibilities to reduce costs, boost efficiency and increase compliance.

From automated Safety Document Distribution and data management to GxP-compliant hosting, pharmasol is focused on delivering service and solution excellence, built on over two decades of unparalleled knowledge of the sector and a rich understanding of your complex business needs.

Safety Letter Notification

psiXchange automates the SUSAR distribution processes to sites, ECs, IRBs and others. This brings increased compliance to this complex distribution process for your critical safety documents.

Find Out More chevron_right

Safety Database

Our rapidLIVE solution delivers an accelerated, pre-packaged implementation for Oracle Argus Safety – currently hosted for many of the top global pharmaceutical companies and CROs

Find Out More chevron_right

20 years’ heritage in serving life sciences organisations worldwide.

pharmasol enables organisations to effectively implement, automate and optimise key regulatory responsibilities across the entire pharmacovigilance function – including SUSAR document distribution via our industry-leading psiXchange platform.

Our full-service portfolio spans innovative software applications, specialist sector consultancy, GxP compliant hosting and gold-standard implementation services – including Argus rapidLIVE.

For over 20 years, we’ve been helping pharmaceutical, biotech and Clinical Research Organisations worldwide companies to efficiently meet their regulatory and operational responsibilities.

Find Out More chevron_right

News and events

pharmasol News: Autumn 2022

14th September 2022

Find out more chevron_right

pharmasol News: Summer 2022

19th July 2022

Find out more chevron_right

Newsletter – Spring 2022

29th March 2022

Find out more chevron_right

We have worked with